Name:Pseudoxanthomonaswinnipegensis Bernard et al. 2020
Category: Species
Proposed as: sp. nov.
Etymology:win.ni.pe.gen’sis.N.L. fem. adj.winnipegensis, pertaining to Winnipeg Manitoba Canada, a traditional homeland for Treaty One Indigenous and Métis Nations and where strains of this species were extensively characterized
Valid publication:
Bernard KA, Vachon A, Pacheco AL, Burdz T, Wiebe D, Beniac DR, Hiebert SL, Booth T, Doyle DA, Lawson P, et al.Pseudoxanthomonas winnipegensis sp. nov., derived from human clinical materials and recovered from cystic fibrosis and other patient types in Canada, and emendation of Pseudoxanthomonas spadix Young et al. 2007. Int J Syst Evol Microbiol 2020; 70:6313-6322. 🇨🇦
IJSEM list:
Oren A, Garrity GM. Notification list. Notification that new names and new combinations have appeared in volume 70, part 12 of the IJSEM. Int J Syst Evol Microbiol 2021; 71:4656.
Nomenclatural status:
validly published under the ICNP
Taxonomic status:
correct name (and explicitly recommended for medical use)
Risk group:
1
Notes:
😷 The risk group for Germany has been imported on 2026-08-13. The full classification is: risk group = 1, note = "+". — If in doubt, use the risk group given in the regulations for your country and, if these are not available, use the risk group given in the catalogue of the culture collection from which you have obtained or intend to obtain the strain.
🎓 Name mentioned 2 times in PubMed until 2026-06-11.
🙆 This name is on the List of Recommended Names for bacteria of medical importance (LoRN) as the name to be applied to this species. The name is on LoRN because of the recorded pathogenicity of the species itself.
🧍 According to Bartlett et al. (2022), this species is an established human pathogen.Publication:
Bartlett A, Padfield D, Lear L, Bendall R, Vos M. A comprehensive list of bacterial pathogens infecting humans. Microbiology (Reading) 2022; 168:0. 🇬🇧
Assigned by:
Bernard KA, Vachon A, Pacheco AL, Burdz T, Wiebe D, Beniac DR, Hiebert SL, Booth T, Doyle DA, Lawson P, et al.Pseudoxanthomonas winnipegensis sp. nov., derived from human clinical materials and recovered from cystic fibrosis and other patient types in Canada, and emendation of Pseudoxanthomonas spadix Young et al. 2007. Int J Syst Evol Microbiol 2020; 70:6313-6322. 🇨🇦
Linking:
To permanently link to this page, use https://doi.org/10.83108/rn.14663Link copied to clipboard